Hypoimmune Stem Cell–Derived Islets: A Next-Generation Cell Therapy Toward a Functional Cure for Type 1 Diabetes Post author: Post published:September 27, 2026 Post category: Continue ReadingHypoimmune Stem Cell–Derived Islets: A Next-Generation Cell Therapy Toward a Functional Cure for Type 1 Diabetes
A First-in-Class CIRSPR-CasX Gene Editing Therapy for Lowering Lp(a) to Prevent Cardiovascular Events Post author: Post published:September 27, 2026 Post category: Continue ReadingA First-in-Class CIRSPR-CasX Gene Editing Therapy for Lowering Lp(a) to Prevent Cardiovascular Events
A first-in-class CRISPR-CasX gene editor silencing APOC3 transcription for the treatment of Severe Hypertriglyceridemia Post author: Post published:September 27, 2026 Post category: Continue ReadingA first-in-class CRISPR-CasX gene editor silencing APOC3 transcription for the treatment of Severe Hypertriglyceridemia
Noncoding RNA drug TY2 for arrhythmogenic cardiomyopathy Post author: Post published:September 27, 2026 Post category: Continue ReadingNoncoding RNA drug TY2 for arrhythmogenic cardiomyopathy
Global gene expression profiling of single inhibitory neurons derived from human stem cells Post author: Post published:September 12, 2024 Post category: Continue ReadingGlobal gene expression profiling of single inhibitory neurons derived from human stem cells
